Journey Medical (DERM) Cash & Equivalents (2020 - 2025)
Historic Cash & Equivalents for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $24.9 million.
- Journey Medical's Cash & Equivalents rose 1088.0% to $24.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year increase of 1088.0%. This contributed to the annual value of $20.3 million for FY2024, which is 2599.95% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Cash & Equivalents is $24.9 million, which was up 1088.0% from $20.3 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Cash & Equivalents ranged from a high of $49.1 million in Q4 2021 and a low of $8.2 million during Q2 2023
- In the last 5 years, Journey Medical's Cash & Equivalents had a median value of $24.7 million in 2023 and averaged $27.1 million.
- Per our database at Business Quant, Journey Medical's Cash & Equivalents soared by 49544.02% in 2021 and then plummeted by 7839.9% in 2023.
- Journey Medical's Cash & Equivalents (Quarter) stood at $49.1 million in 2021, then crashed by 34.82% to $32.0 million in 2022, then decreased by 14.26% to $27.4 million in 2023, then dropped by 26.0% to $20.3 million in 2024, then increased by 22.87% to $24.9 million in 2025.
- Its last three reported values are $24.9 million in Q3 2025, $20.3 million for Q2 2025, and $21.1 million during Q1 2025.